Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – In an organic compound
Reexamination Certificate
2006-05-02
2006-05-02
Jones, Dameron L. (Department: 1618)
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
In an organic compound
C424S001110, C424S001650, C558S160000
Reexamination Certificate
active
07037486
ABSTRACT:
The present invention provides novel compounds comprising cellular phosphoinositides and analogues tagged with stable or radioactive isotopes. The present invention also provides novel methods for the preparation of the said phosphoinositides by syntheses, and novel key intermediates of synthesis; the novel methods of synthesis are applied also for the preparation of the phosphoinositides in non-labelled form. In addition, the present invention discloses a class of novel compounds as isotope labelled key precursors of labelled phosphoinositides. These precursors are derivatives of the target phosphoinositides, labelled with stable or radioactive isotopes, wherein OH and phosphate groups are blocked with temporary protecting groups.
REFERENCES:
patent: 5227508 (1993-07-01), Kozikowski et al.
patent: 6376697 (2002-04-01), Aneja
Aneja et al., “A General Synthesis of Glycerophospholipids,”Biochim Biophys. Acta, 218:102-111. 1970.
Aneja and Parra , “Facile Optical Resolution of DL-1,4,5,6-Tetra-O-Benzyl-MYO-Inositol: Key Synthons for the Phosphoinositides,”Tetrahedon Lett., 35:525-526, 1994.
Aneja et al., “The Absolute Configuration and Optical Purity of (−)- and (+)- 1,2:4,5-Di-O-Cyclohexylidene-MYO-Inositols,”Tetrahedron Asymmetry, 6:17-18, 1995.
Aneja et al., “A Unified Approach to Unambiguous Synthesis of the Phosphatidylinositol-3-Phosphates Involved in Intracellular Signal Transduction,”Tetrahedron Lett., 38:803-806, 1997.
Bannwarth and Trzeciak, “A Simple and Effective Chemical Phosphorylation Procedure for Biomolecules,”Helv. Chim. Acta, 70:175-186, 1987.
Berridge, “Inositol Trisphosphate and Diacylglycerol: Two Interacting Second Messengers,”Annu. Rev. Biochem., 56:159-193, 1987.
Berridge, “Inositol Trisphosphate and Calcium Signalling,”Nature, 361:315-325, 1993.
Bruzik and Kubiak, “General Synthesis of Phosphatidylinositol 3-Phosphates,”Tetrahedron Lett., 36:2415-2418, 1995.
Chen et al., Synthesis of Photoactivatable 1,2,O-Ddiacyl-sn-Glycerol Derivatives of 1-L-Phosphatidyl-D-MYO-Inositol 4,5-Bisphosphate (PtdInsP2) and 3,4,5-Trisphosphate(PtdInslP3) ,J. Org. Chem., 61:6305-6312, 1996.
Chen and Prestwich, “Synthesis of a Tritium-Labelled Diether Analog of Phosphatidylinositol 4,5-Bisphosphate,”J. Labelled Compounds and Radiopharmaceuticals, 39:251-258, 1997.
Duckworth and Cantley, “PI 3-Kinase and Receptor-Linked Signal Transduction,”Lipid Second Messengers—Handbook of Lipid Research; Plenum Press: New York, NY, vol. 8, pp. 125-175, 1996.
Gaffney and Reese, “Synthesis of 1-O-Stearoyl-2-O-Arachidonoyl-sn-Glycer-3-YL-D-MYO-Inositol 3,4,5-Trisphosphate and its Stereoisomers,”Bioorg. Med. Chem. Lett., 7:3171-3176, 1997.
Gou and Chen, “Synthesis of L-α-Phosphatidyl-D-MYO-Inositol 3,4,5-Trisphosphate, an Important Intracellular Signalling Molecule,”J. Chem. Soc., Chem. Commun., 2126-2126, 1994.
Grove et al., “Synthesis of Dipalmitoyl Phosphatidylinositol 3,4,bis(phosphate) and 3,4,5-tris(phosphate) and their Enantiomers,”J. Chem. Soc., Chem. Commun., 1635-1636, 1997.
Lee and Rhee, “Significant of PIP2Hydrolysis and Regulation of Phospholipase C Isozymes,”Curr. Opin. Cell Biol., 7:183-189, 1995.
Stephens et al., “Synthesis of Phosphatidylinositol 3,4,5-Trisphosphate in Permeabilized Neutrophils Regulated by Receptors and G-Proteins,”J. Biol. Chem., 268:17162-17172, 1993.
Terui et al., “Effects of Acid Phospholipids on Nucleotide Exchange Properties of ADP-Ribosylation Factor 1,”J. Biol. Chem., 269:28130-28135, 1994.
Toker et al., “Activation of Protein Kinase C Family Members by the Novel Polyphosphoinositides PtdIns-3,4-P2and PtdIns-3,4,5-P3,”J. Biol. Chem., 269:32358-32367, 1994.
Watanabe et al., “Synthesis of a Phosphatidylinositol 3,4,5-Trisphosphate,”Tetrahedron Lett., 35:123-124, 1994.
Watanabe et al., “Synthesis of 1D-Distearoylphosphatidyl-MYO-Insitol 3,4,5-Tris(Dihydrogen Phosphate),”Tetrahedron, 51:8969-8976, 1995.
Watanabe et al., “Protection of Phosphate with the 9-Fluorenylmethyl Group. Synthesis of Unsaturated-Acyl Phosphatidylinositol 4,5-Bisphosphate,”Tetrahedron Lett., 38::7407-7410, 1997.
Watanabe and Nakatomi, “Synthesis of Natural PI(3,4,5)P3,”Tetrahedron Lett., 39:1583-1586, 1998.
Whitman et al., “Evidence for Two Distinct Phosphatidylinositol Kinases in Fibroblasts,”Biochem. J., 247:165-174, 1987.
Whitman et al., “Type I Phosphatidylinositol Kinase makes a Novel Inositol Phospholipid, Phosphatidylinositol-3-Phosphate,”Nature, 332:644-646, 1988.
Jones Dameron L.
Nutrimed Biotech
LandOfFree
Labelled phosphoinositides and analogues does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Labelled phosphoinositides and analogues, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Labelled phosphoinositides and analogues will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3538134